CLINICAL_TRIALS
research
· 2025-10-31
Clinical Trial Update: REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center [NA]
Summary
This update describes the REVASC-PAD feasibility study on restricted vascular exercise for peripheral arterial disease at the University of Tennessee Medical Ce…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Peripheral Arterial Disease | NA | Status: NOT_YET_RECRUITING